Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 19)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
8-Feb-10PriceTarget Research, Inc.N/ATrinity Biotech PLC has a current Overall Rating of C (Neutral).7$25  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for TRIB: the economy's impact on TRIB's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC5$25  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC5$25  View Abstract
20-Jan-10Zacks Investment Research Inc.N/ATRINITY BIOTECH (TRIB) Zacks Company Snapshot1$10  View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC5$25  View Abstract
13-Jan-10Life Science AnalyticsLife Science AnalyticsTrinity Biotech Plc-Company Report21$150  View Abstract
6-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update8$254 Stars  View Abstract
6-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary14$50  View Abstract
Next 9
Brokerage Reports (Showing 1 to 2 of 2)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
6-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update8$254 Stars  View Abstract
6-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary14$50  View Abstract
Independent Reports (Showing 1 to 10 of 17)
Release
Date [down]		 Contributor Author Title Pages Price More Info
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
8-Feb-10PriceTarget Research, Inc.N/ATrinity Biotech PLC has a current Overall Rating of C (Neutral).7$25View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for TRIB: the economy's impact on TRIB's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC5$25View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC5$25View Abstract
20-Jan-10Zacks Investment Research Inc.N/ATRINITY BIOTECH (TRIB) Zacks Company Snapshot1$10View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC5$25View Abstract
13-Jan-10Life Science AnalyticsLife Science AnalyticsTrinity Biotech Plc-Company Report21$150View Abstract
5-Jan-10Zacks Investment Research Inc.N/ATRINITY BIOTECH (TRIB) Zacks Company Snapshot1$10View Abstract
5-Jan-10Global Markets DirectGlobal Markets DirectTrinity Biotech Plc Financial and Strategic Analysis Review35$300View Abstract
Next 7

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.